Health In Tech, Inc. (NASDAQ:HIT) Short Interest Down 68.8% in December

Health In Tech, Inc. (NASDAQ:HIT) was the target of a significant decrease in short interest in December. As of December 15th, there was short interest totaling 132,749 shares, a decrease of 68.8% from the November 30th total of 425,649 shares. Based on an average daily trading volume, of 763,353 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.2% of the company’s stock are sold short. Currently, 0.2% of the company’s stock are sold short. Based on an average daily trading volume, of 763,353 shares, the days-to-cover ratio is presently 0.2 days.

Institutional Trading of Health In Tech

Hedge funds have recently added to or reduced their stakes in the stock. Raymond James Financial Inc. bought a new position in shares of Health In Tech during the 3rd quarter valued at approximately $45,000. Squarepoint Ops LLC bought a new stake in shares of Health In Tech in the 3rd quarter worth approximately $46,000. Millennium Management LLC purchased a new position in Health In Tech in the third quarter valued at approximately $85,000. Cubist Systematic Strategies LLC bought a new position in Health In Tech during the first quarter valued at $41,000. Finally, Arete Wealth Advisors LLC purchased a new stake in Health In Tech in the first quarter worth $47,000.

Health In Tech Trading Up 4.1%

Shares of Health In Tech stock opened at $1.52 on Thursday. The business’s fifty day simple moving average is $1.93 and its 200 day simple moving average is $2.11. Health In Tech has a 12 month low of $0.51 and a 12 month high of $7.59. The firm has a market capitalization of $86.50 million and a P/E ratio of 50.67.

Health In Tech (NASDAQ:HIT) last announced its earnings results on Wednesday, November 12th. The company reported $0.01 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.01. The business had revenue of $8.49 million for the quarter, compared to analysts’ expectations of $7.05 million.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Weiss Ratings restated a “sell (d-)” rating on shares of Health In Tech in a research note on Wednesday, October 8th. Wall Street Zen downgraded shares of Health In Tech from a “buy” rating to a “hold” rating in a report on Sunday, November 16th. One analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Health In Tech presently has an average rating of “Moderate Buy” and a consensus price target of $2.50.

About Health In Tech

Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.